⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SGBX News
Safe & Green Holdings Corp. Common Stock
Samsung Bioepis beginnt mit der Vermarktung von BYOOVIZ ®, einem Biosimilar zu Lucentis (Ranibizumab), in Europa
businesswire.com
SGBX
Safe & Green Holdings Adjourns 2025 Annual Meeting Due to Lack of Quorum; Sets Virtual Reconvening for Jan. 14
globenewswire.com
SGBX
Safe & Green Holdings Completes Strategic Acquisition of Giant Containers
globenewswire.com
SGBX
TSLA
AMZN
GM
La présentation en seringue préremplie de BYOOVIZ®, le médicament biosimilaire de Lucentis (ranibizumab) de Samsung Bioepis, obtient l’autorisation européenne
businesswire.com
SGBX
RHHBY
Vorgefüllte Spritze BYOOVIZ® von Samsung Bioepis, das Biosimilar zu Lucentis (Ranibizumab), erhält europäische Zulassung
businesswire.com
SGBX
RHHBY
Epicutis® Lipid Shield SPF 30 Achieves EWG Verified® Status
prnewswire.com
SGBX
Olenox Receives DOT Number; Prepares To Mobilize Service Division Assets
globenewswire.com
SGBX
Safe & Green Holdings Outlines New Integrated Energy Strategy Following First Year Under Olenox Leadership
globenewswire.com
SGBX
Safe and Green Holdings Announces Its 2025 Record Date and Annual Shareholders Meeting Date
globenewswire.com
SGBX
SGBX Subsidiary Olenox to Implement AI Algorithm to Streamline Wellsite Production and Operator Input
globenewswire.com
SGBX